Search research articles
Contact Us
Filters
Showing results (271-280 of 403) with videos related to
Page
of 41
Sort By:
Plos One
|
February 6, 2016
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
Tue Wenzel Kragstrup, Babak Jalilian, Kresten Krarup Keller, et al.
Arthritis Research & Therapy
|
March 5, 2024
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis
Jianyang Liu, Helena Idborg, Marina Korotkova, et al.
Arthritis Research & Therapy
|
March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
Tue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
Annals of the Rheumatic Diseases
|
March 23, 2016
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques
Philip G Conaghan, Mikkel Østergaard, Michael A Bowes, et al.
Annals of the Rheumatic Diseases
|
June 28, 2018
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, et al.
The Journal of Rheumatology
|
May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions
John T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
The Journal of Rheumatology
|
December 17, 2018
Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS)
Féline P B Kroon, Sjoerd van Beest, Frédérique Gandjbakhch, et al.
Annals of the Rheumatic Diseases
|
September 4, 2012
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases
|
February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Clinical and Experimental Rheumatology
|
November 19, 2021
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis
Jonathan Aldridge, Anna-Carin Lundell, Kerstin Andersson, et al.
Page
of 41
Search research articles
Search
Showing results (271-280 of 403) with videos related to
Sort By:
Page
of 41
Plos One
|
February 6, 2016
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
Tue Wenzel Kragstrup, Babak Jalilian, Kresten Krarup Keller, et al.
Arthritis Research & Therapy
|
March 5, 2024
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis
Jianyang Liu, Helena Idborg, Marina Korotkova, et al.
Arthritis Research & Therapy
|
March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
Tue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
Annals of the Rheumatic Diseases
|
March 23, 2016
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques
Philip G Conaghan, Mikkel Østergaard, Michael A Bowes, et al.
Annals of the Rheumatic Diseases
|
June 28, 2018
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten, Mikkel Østergaard, James Cheng-Chung Wei, et al.
The Journal of Rheumatology
|
May 8, 2003
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions
John T Sharp, Désirée Van Der Heijde, Maarten Boers, et al.
The Journal of Rheumatology
|
December 17, 2018
Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS)
Féline P B Kroon, Sjoerd van Beest, Frédérique Gandjbakhch, et al.
Annals of the Rheumatic Diseases
|
September 4, 2012
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry
Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases
|
February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Clinical and Experimental Rheumatology
|
November 19, 2021
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis
Jonathan Aldridge, Anna-Carin Lundell, Kerstin Andersson, et al.
Page
of 41